2026Q1
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Baskett Forest | 10% Owner | 10,421,428 | Apr 13, 2022 |
| New Enterprise Associates 16, L.P. | 10% Owner | 10,421,428 | Apr 13, 2022 |
| NEA Partners 16, L.P. | 10% Owner | 10,421,428 | Apr 13, 2022 |
| Nea 16 Gp, Llc | 10% Owner | 10,421,428 | Apr 13, 2022 |
| Tpg Gp A, Llc | Other | 3,824,883 | Jul 6, 2022 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | Feb 20, 2026 | Cassella James V | Chief Development Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 19, 2026 | Feb 20, 2026 | Galletta Christopher | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 19, 2026 | Feb 20, 2026 | SCIASCIA THOMAS | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 19, 2026 | Feb 20, 2026 | GOOD JENNIFER L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 19, 2026 | Feb 20, 2026 | Simon Farrell | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 17, 2025 | Feb 13, 2026 | Florence Anthony A. Jr. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 17, 2025 | Feb 13, 2026 | SANDELL SCOTT D | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 17, 2025 | Feb 13, 2026 | Behbahani Ali | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 17, 2025 | Feb 13, 2026 | BASKETT FOREST | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 17, 2025 | Feb 13, 2026 | Makhzoumi Mohamad | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 17, 2025 | Feb 13, 2026 | Walker Paul Edward | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 17, 2025 | Feb 13, 2026 | New Enterprise Associates 16, L.P. | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 17, 2025 | Feb 13, 2026 | Chang Carmen | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 8, 2026 | Jan 12, 2026 | HASTINGS DAVID C | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2026 | HASTINGS DAVID C | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 2, 2025 | Dec 3, 2025 | Galletta Christopher | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Mathers Edward T | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Colangelo Dominick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Heffernan Michael Thomas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | VANLENT ANNE | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 11, 2025 | Jun 13, 2025 | Meeker David P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 31, 2025 | Jun 3, 2025 | Galletta Christopher | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 31, 2025 | Jun 3, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 31, 2025 | Jun 3, 2025 | Delfini Lisa | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 31, 2025 | Jun 3, 2025 | Simon Farrell | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 31, 2025 | Jun 3, 2025 | GOOD JENNIFER L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 25, 2025 | Mar 26, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 26.3 | -2,631 | -1.17% | ✗ | $17.4K |
| Mar 21, 2025 | Mar 25, 2025 | GOOD JENNIFER L | CEO | Sell | 26.3 | -5,263 | -2.41% | ✗ | $34.6K |
| Mar 10, 2025 | Mar 12, 2025 | GOOD JENNIFER L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 10, 2025 | Mar 12, 2025 | Delfini Lisa | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 10, 2025 | Mar 12, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 10, 2025 | Mar 12, 2025 | Galletta Christopher | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 10, 2025 | Mar 12, 2025 | Simon Farrell | Chief Commercial Officer | Sell | 7.5 | -81,313 | -51.39% | ✓ | $548.9K |
| Feb 18, 2025 | Feb 20, 2025 | SCIASCIA THOMAS | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2025 | Feb 20, 2025 | Cassella James V | Chief Development Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2025 | Feb 20, 2025 | Simon Farrell | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2025 | Feb 20, 2025 | Delfini Lisa | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2025 | Feb 20, 2025 | Galletta Christopher | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 18, 2025 | Feb 20, 2025 | GOOD JENNIFER L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 7, 2025 | Jan 10, 2025 | Delfini Lisa | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Dec 13, 2024 | Dec 17, 2024 | Galletta Christopher | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 30, 2024 | Oct 1, 2024 | Cassella James V | Chief Development Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 6, 2024 | Sep 9, 2024 | GOOD JENNIFER L | CEO | Sell | 26.3 | -6,059 | -1.40% | ✗ | $18.4K |
| Sep 3, 2024 | Sep 5, 2024 | GOOD JENNIFER L | CEO | Sell | 22.5 | -55,121 | -7.93% | ✗ | $170.2K |
| Aug 27, 2024 | Aug 29, 2024 | Meeker David P | Director | Sell | 26.3 | -4,555 | -1.28% | ✗ | $13.4K |
| Aug 19, 2024 | Aug 21, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 26.3 | -16,496 | -6.97% | ✗ | $48.9K |
| Aug 14, 2024 | Aug 16, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 22.5 | -31,505 | -4.55% | ✗ | $87.2K |
| Jun 13, 2024 | Jun 14, 2024 | Mathers Edward T | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 13, 2024 | Jun 14, 2024 | Cassella James V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 13, 2024 | Jun 14, 2024 | Heffernan Michael Thomas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 13, 2024 | Jun 14, 2024 | Meeker David P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 13, 2024 | Jun 14, 2024 | VANLENT ANNE | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 13, 2024 | Jun 14, 2024 | Colangelo Dominick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| May 29, 2024 | May 31, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | Sell | 42.5 | -53,368 | -19.93% | ✗ | $136.1K |
| May 22, 2024 | May 24, 2024 | Delfini Lisa | CFO | Sell | 46.3 | -4,350 | -7.55% | ✗ | $11.5K |
| May 20, 2024 | May 22, 2024 | GOOD JENNIFER L | CEO | Sell | 22.5 | -25,037 | -10.50% | ✗ | $71.6K |
| May 10, 2024 | May 14, 2024 | GOOD JENNIFER L | CEO | Sell | 26.3 | -4,578 | -2.10% | ✗ | $13.3K |
| Feb 15, 2024 | Feb 16, 2024 | Galletta Christopher | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 15, 2024 | Feb 16, 2024 | Simon Farrell | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 15, 2024 | Feb 16, 2024 | Clark David J | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 15, 2024 | Feb 16, 2024 | GOOD JENNIFER L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 15, 2024 | Feb 16, 2024 | SCIASCIA THOMAS | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 15, 2024 | Feb 16, 2024 | Delfini Lisa | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2023 | Oct 12, 2023 | Delfini Lisa | CFO | Sell | 46.3 | -785 | -2.14% | ✓ | $1.6K |
| Sep 11, 2023 | Sep 13, 2023 | Delfini Lisa | CFO | Sell | 46.3 | -711 | -2.03% | ✓ | $1.6K |
| Aug 11, 2023 | Aug 14, 2023 | Delfini Lisa | CFO | Sell | 46.3 | -682 | -2.04% | ✓ | $1.6K |
| Jul 11, 2023 | Jul 12, 2023 | Delfini Lisa | CFO | Sell | 46.3 | -687 | -2.15% | ✓ | $1.6K |
| Jun 28, 2023 | Jun 30, 2023 | Mathers Edward T | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 28, 2023 | Jun 30, 2023 | Cassella James V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 28, 2023 | Jun 30, 2023 | Heffernan Michael Thomas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 28, 2023 | Jun 30, 2023 | Meeker David P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 28, 2023 | Jun 30, 2023 | Colangelo Dominick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 28, 2023 | Jun 30, 2023 | VANLENT ANNE | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 20, 2023 | Jun 21, 2023 | Simon Farrell | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 12, 2023 | Jun 14, 2023 | Delfini Lisa | CFO | Sell | 46.3 | -610 | -2.02% | ✓ | $1.6K |
| May 11, 2023 | May 15, 2023 | Delfini Lisa | CFO | Sell | 50.0 | -562 | -1.97% | ✓ | $1.6K |
| Apr 11, 2023 | Apr 12, 2023 | Delfini Lisa | CFO | Sell | 42.5 | -840 | -3.11% | ✓ | $1.5K |
| Mar 13, 2023 | Mar 15, 2023 | Delfini Lisa | CFO | Sell | 42.5 | -892 | -3.48% | ✓ | $1.6K |
| Mar 7, 2023 | Mar 8, 2023 | Simon Farrell | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2023 | Feb 16, 2023 | Galletta Christopher | Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2023 | Feb 16, 2023 | Simon Farrell | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2023 | Simon Farrell | Chief Commercial Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Feb 16, 2023 | Feb 16, 2023 | SCIASCIA THOMAS | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2023 | Feb 16, 2023 | Delfini Lisa | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2023 | Feb 16, 2023 | GOOD JENNIFER L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 13, 2023 | Feb 15, 2023 | Delfini Lisa | CFO | Sell | 13.8 | -8,474 | -26.64% | ✓ | $20.8K |
| Nov 14, 2022 | Nov 14, 2022 | Clark David J | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 14, 2022 | Clark David J | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 19, 2022 | Sep 19, 2022 | SCIASCIA THOMAS | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 19, 2022 | Sep 19, 2022 | GOOD JENNIFER L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 1, 2022 | Jul 6, 2022 | TPG GP A, LLC | Other | Sell | 17.5 | -500,000 | -11.56% | ✗ | $1.4M |
| Jun 23, 2022 | Jul 1, 2022 | VANLENT ANNE | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jul 1, 2022 | Meeker David P | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jul 1, 2022 | Heffernan Michael Thomas | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jul 1, 2022 | Colangelo Dominick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 23, 2022 | Jul 1, 2022 | Cassella James V | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 29, 2022 | Jul 1, 2022 | SCIASCIA THOMAS | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 29, 2022 | Jul 1, 2022 | Forbes William P | Chief Development Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jun 29, 2022 | Jul 1, 2022 | GOOD JENNIFER L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 11, 2022 | Jul 1, 2022 | SCIASCIA THOMAS | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |